Innovative drug approvals vs Clinical trial country use share in China
Innovative drug approvals and Clinical trial country use share in China, compared over time.
Change the pair
Compare different indicators
The series
Over time
China, spaced by time . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.
Innovative drug approvals
Unit: count · 2 observations
Clinical trial country use share
Unit: % · 3 observations
Provenance
Where these numbers come from
Innovative drug approvals
Total number of innovative pharmaceutical products granted regulatory marketing authorization.
2 observations in China · source organisations: NHSA
Clinical trial country use share
Percentage of total clinical trial country uses accounted for by a given region.
3 observations in China · source organisations: IQVIA
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring